Latest Content

Nicholas Hornstein, MD, PhD discusses ctDNA in colorectal cancer, the INTERCEPT-TT trial, building Northwell's GI oncology program, and what better drugs will look like.

A cancer survivor reflects on the receptionists, medical assistants and nurses whose kindness made treatment more manageable and less frightening.

Aurora Relampagos blends clinical expertise with compassion, leading scheduling innovations that cut wait times while mentoring colleagues and staff.

He thought CAR-T therapy marked the end of cancer. Months later, another diagnosis revealed the power of faith, hope and resilience.

Diagnosed with Hodgkin lymphoma at 18, Steve Garraty shares how survivorship, gratitude and purpose emerged from life's hardest chapter.

14 years after a rare lymphoma diagnosis, Edward Miskie answers real questions on survivorship, caregiving and life after cancer treatment.

After a kidney lesion proved unlikely to be cancer, a survivor embraces self-care, friendship and new opportunities with renewed gratitude and joy.

FDA approves Trodelvy alone or with Keytruda for the first-line treatment of adults with unresectable locally advanced or metastatic triple-negative breast cancer.

Susan Yaguda, oncology nurse at Atrium Health Levine Cancer Institute, transforms cancer care by treating the whole person — mind, body, and spirit — one patient at a time.

A four-time cancer survivor shares how the Mariana Trench mirrors the journey through cancer, resilience, hope, and survival.

Nurse Navigator Nicola Stewart helped a Vietnamese-speaking patient with metastatic colon cancer overcome language, financial and care barriers.

FDA grants full approval to TECELRA and expands its use to eligible patients ages 12 and older with advanced synovial sarcoma after chemotherapy.

A cancer survivor shares what happens when a routine surveillance scan brings an unexpected finding — and how she navigated scanxiety, surgery, and an NED result.